F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots

But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech or Moderna booster, an action that an F.D.A. official said was possible.

from NYT > U.S. > Politics https://ift.tt/3BO1uUQ